{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:32:44Z","timestamp":1769574764499,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.abd.2025.501230","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:30:53Z","timestamp":1761971453000},"page":"501230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy of topical calcineurin inhibitor therapy for childhood vitiligo: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7674-0879","authenticated-orcid":false,"given":"Tiande","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2025.501230_bib0005","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kr\u0171ger","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/pde.12226","article-title":"Quality of life impairment in children and adolescents with vitiligo","volume":"31","author":"Silverberg","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s41687-020-0186-2","article-title":"Childhood vitiligo impacts emotional health of parents: a prospective, cross-sectional study of quality of life for primary caregivers","volume":"4","author":"Andrade","year":"2020","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.abd.2025.501230_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.det.2016.11.007","article-title":"Medical and maintenance treatments for vitiligo","volume":"35","author":"Passeron","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2025.501230_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(20)30747-9","article-title":"First step in a new era for treatment of patients with vitiligo","volume":"396","author":"Passeron","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.abd.2025.501230_bib0030","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40257-019-00430-0","article-title":"Childhood vitiligo","volume":"20","author":"Nicolaidou","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0035","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.3760\/cma.j.issn.0366-6999.20140314","article-title":"Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells","volume":"127","author":"Huang","year":"2014","journal-title":"Chin Med J"},{"key":"10.1016\/j.abd.2025.501230_bib0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000083516","article-title":"Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus","volume":"210","author":"Fricain","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2025.501230_bib0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41390-022-02133-5","article-title":"Impacts of exposure to topical calcineurin inhibitors on metabolism in vitiligo infants","volume":"93","author":"Hu","year":"2023","journal-title":"Pediatr Res"},{"key":"10.1016\/j.abd.2025.501230_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.abd.2025.501230_bib0055","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.abd.2025.501230_bib0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.abd.2025.501230_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches the GRADE working group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.abd.2025.501230_bib0070","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2133.2011.10351.x","article-title":"A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0\u00b705% in childhood vitiligo","volume":"165","author":"Ho","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0075","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1111\/pde.13726","article-title":"The effectiveness of topical therapy combined with 308-nm excimer laser on vitiligo compared to excimer laser monotherapy in pediatric patients","volume":"36","author":"Li","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0080","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pde.12991","article-title":"Treatment of childhood vitiligo using tacrolimus ointment with narrowband ultraviolet B phototherapy","volume":"33","author":"Dayal","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/09546630903266761","article-title":"Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo","volume":"21","author":"K\u00f6se","year":"2010","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.abd.2025.501230_bib0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1525-1470.2009.00926.x","article-title":"The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study","volume":"26","author":"Farajzadeh","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1525-1470.2009.00914.x","article-title":"Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo","volume":"26","author":"Hui-Lan","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0105","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2296851","article-title":"Efficacy and safety of 308-nm excimer lamp combined with tacrolimus 0.1% ointment vs tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial","volume":"35","author":"Alshiyab","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.abd.2025.501230_bib0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09546634.2020.1729952","article-title":"Comparison of the efficacy of tacrolimus 0.1% ointment and tacrolimus 0.1% plus topical pseudocatalase\/superoxide dismutase gel in children with limited vitiligo: a randomized controlled trial","volume":"33","author":"Alshiyab","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.abd.2025.501230_bib0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2019.07.108","article-title":"The effectiveness of topical calcineurin inhibitors compared with topical corticosteroids in the treatment of vitiligo: a systematic review and meta-analysis","volume":"82","author":"Chang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jamadermatol.2024.0021","article-title":"Expert recommendations on use of topical therapeutics for vitiligo in pediatric, adolescent, and young adult patients","volume":"160","author":"Renert-Yuval","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jdermsci.2009.02.002","article-title":"Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis","volume":"54","author":"El-Batawy","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.abd.2025.501230_bib0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0135","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-2133.2006.07467.x","article-title":"FK506 increases pigmentation and migration of human melanocytes","volume":"155","author":"Kang","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00403-009-0973-3","article-title":"Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus","volume":"302","author":"Lubaki","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.abd.2025.501230_bib0145","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ajd.13096","article-title":"The efficacy and safety of tacrolimus as mono- and adjunctive therapy for vitiligo: A systematic review of randomised clinical trials","volume":"61","author":"Arora","year":"2020","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1525-1470.2010.01223.x","article-title":"The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis","volume":"27","author":"McCollum","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0155","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/1346-8138.14501","article-title":"Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits","volume":"45","author":"Ohtsuki","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2025.501230_bib0160","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.jid.5700622","article-title":"Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis","volume":"127","author":"Arellano","year":"2007","journal-title":"J Invest Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059625001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059625001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T23:26:28Z","timestamp":1766186788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059625001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0365059625001722"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2025.501230","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of topical calcineurin inhibitor therapy for childhood vitiligo: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2025.501230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501230"}}